Skip to content

NewAmsterdam Pharma Co N.V.

NAMSW· NasdaqCore metricsCIK 1936258

Pharmaceutical preparations552 peers

Close
Jun 30, 2026
Market cap
—
no share count on file
Filings
417
$19.16M
Q3 2026−50.6% FY25 yoy
-$17.39M
Q3 2026N/M FY25 yoy
-$44.19M
Q3 2026N/M FY25 yoy
-$109.89M
Q3 2026derivedN/M FY25 yoy
-$0.14
Q3 2026N/M FY25 yoy
$423.13M
Q3 2026−36.5% FY25 yoy

Price

$21.37+167.13%+$13.37past year
Jun 30, 2026 · 13F quarter end
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$22.50MFY 2025
$102.69M0FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$22,503,000reported
FY 20242024-12-31$45,563,000reported
FY 20232023-12-31$14,090,000reported
FY 20222022-12-31$102,694,000reported

Pharmaceutical preparations

NewAmsterdam Pharma Co N.V. is the 151st largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

NewAmsterdam Pharma Co N.V. · CIK 1936258 · Engraved from SEC EDGAR